Man Group PLC Adaptive Biotechnologies Corp Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Man Group PLC holds 160,372 shares of ADPT stock, worth $752,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160,372

Previous 184,451 13.05%

Holding current value

$752,144

Previous $667,000 23.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.37 - $5.12 $81,146 - $123,284	-24,079 Reduced 13.05%	160,372 $821,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $15,078 - $25,518	6,444 Added 3.62%	184,451 $667,000
Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $19,981 - $33,302	6,938 Added 4.06%	178,007 $571,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $181,743 - $279,968	52,527 Added 44.31%	171,069 $838,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $20,107 - $33,473	-3,966 Reduced 3.24%	118,542 $646,000
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $95,753 - $135,817	15,469 Added 14.45%	122,508 $822,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $103,545 - $134,210	13,275 Added 14.16%	107,039 $945,000
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $371,136 - $553,740	-59,287 Reduced 38.74%	93,764 $716,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $109,947 - $214,313	-16,915 Reduced 9.95%	153,051 $1.09 Million
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $513,715 - $1.18 Million	80,268 Added 89.49%	169,966 $1.38 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $81,992 - $234,147	8,102 Added 9.93%	89,698 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $679,111 - $994,249	-26,981 Reduced 24.85%	81,596 $2.29 Million
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $10,927 - $14,512	-364 Reduced 0.33%	108,577 $3.69 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $1.15 Million - $1.6 Million	-35,794 Reduced 24.73%	108,941 $4.45 Million
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $112,860 - $205,184	3,029 Added 2.14%	144,735 $5.83 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $152,943 - $222,467	-3,398 Reduced 2.34%	141,706 $8.38 Million
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $412,551 - $562,632	-11,527 Reduced 7.36%	145,104 $7.06 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $3.35 Million - $6.5 Million	134,288 Added 601.03%	156,631 $7.58 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $6.93 Million - $14 Million	-408,466 Reduced 94.81%	22,343 $621,000
Q4 2019 Feb 18, 2020	BUY	$24.56 - $32.8 $9.07 Million - $12.1 Million	369,397 Added 601.51%	430,809 $12.9 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $1.86 Million - $3.29 Million	61,412 New	61,412 $1.9 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account